Interleukin-2, interleukin-15, and their roles in human natural killer cells

被引:252
作者
Becknell, B [1 ]
Caligiuri, MA
机构
[1] Ohio State Univ, Med Sci Program, Columbus, OH 43210 USA
[2] Ohio State Univ, Integrated Biomed Grad Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[4] Ohio State Univ, Div Hematol Oncol, Columbus, OH 43210 USA
[5] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
来源
ADVANCES IN IMMUNOLOGY, VOL 86 | 2005年 / 86卷
关键词
D O I
10.1016/S0065-2776(04)86006-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK) cells are CD56(+)CD3(-) large granular lymphocytes that constitute a key component of the human innate immune response. In addition to their potent cytolytic activity, NK cells elaborate a host of immunoregulatory cytokines and chemokines that play a crucial role in pathogen clearance. Furthermore, interactions between NK and other immune cells are implicated in triggering the adaptive, or antigen-specific, immune response. Interleukin-2 (IL-2) and IL-15 are two distinct cytokines with partially overlapping properties that are implicated in the development, homeostasis, and function of NK cells. This review examines the pervasive effects of IL-2 and IL-15 on NK cell biology, with an emphasis on recent discoveries and lingering challenges in the field.
引用
收藏
页码:209 / 239
页数:31
相关论文
共 111 条
  • [1] ANDERSON DM, 1995, J BIOL CHEM, V270, P29862
  • [2] IL-15-mediated induction of LFA-1 is a late step required for cytotoxic differentiation of human NK cells from CD34+Lin- bone marrow cells
    Barao, I
    Hudig, D
    Ascensao, JL
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (02) : 683 - 690
  • [3] PROLONGED ADMINISTRATION OF LOW-DOSE INTERLEUKIN-2 IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED MALIGNANCY RESULTS IN SELECTIVE EXPANSION OF INNATE IMMUNE EFFECTORS WITHOUT SIGNIFICANT CLINICAL TOXICITY
    BERNSTEIN, ZP
    PORTER, MM
    GOULD, M
    LIPMAN, B
    BLUMAN, EM
    STEWART, CC
    HEWITT, RG
    FYFE, G
    POIESZ, B
    CALIGIURI, MA
    [J]. BLOOD, 1995, 86 (09) : 3287 - 3294
  • [4] INTERLEUKIN-2-INDUCED PROLIFERATION OF MURINE NATURAL-KILLER CELLS INVIVO
    BIRON, CA
    YOUNG, HA
    KASAIAN, MT
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) : 173 - 188
  • [5] Fibroblasts from human spleen regulate NK cell differentiation from blood CD34+ progenitors via cell surface IL-15
    Briard, D
    Brouty-Boyé, D
    Azzarone, B
    Jasmin, C
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (09) : 4326 - 4332
  • [6] SHWARTZMAN REACTION
    BROZNA, JP
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1990, 16 (04) : 326 - 332
  • [7] RETRACTED: The IL-15Rα chain signals through association with Syk in human B cells (Retracted article. See vol. 186, pg. 2681, 2011)
    Bulanova, E
    Budagian, V
    Pohl, T
    Krause, H
    Dürkop, H
    Paus, R
    Bulfone-Paus, S
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (11) : 6292 - 6302
  • [8] RETRACTED: Death deflected:: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Rα chain (Retracted Article. See vol 25, pg 1118, 2011)
    Bulfone-Paus, S
    Bulanova, E
    Pohl, T
    Budagian, V
    Dürkop, H
    Rückert, R
    Kunzendorf, U
    Paus, R
    Krause, H
    [J]. FASEB JOURNAL, 1999, 13 (12) : 1575 - 1585
  • [9] A LYMPHOKINE, PROVISIONALLY DESIGNATED INTERLEUKIN-T AND PRODUCED BY A HUMAN ADULT T-CELL LEUKEMIA LINE, STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS
    BURTON, JD
    BAMFORD, RN
    PETERS, C
    GRANT, AJ
    KURYS, G
    GOLDMAN, CK
    BRENNAN, J
    ROESSLER, E
    WALDMANN, TA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) : 4935 - 4939
  • [10] SELECTIVE MODULATION OF HUMAN NATURAL-KILLER-CELLS INVIVO AFTER PROLONGED INFUSION OF LOW-DOSE RECOMBINANT INTERLEUKIN-2
    CALIGIURI, MA
    MURRAY, C
    ROBERTSON, MJ
    WANG, E
    COCHRAN, K
    CAMERON, C
    SCHOW, P
    ROSS, ME
    KLUMPP, TR
    SOIFFER, RJ
    SMITH, KA
    RITZ, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) : 123 - 132